• >
  • >
  • >
  • >
  • >
Upload Avatar (500 x 500)
Bo-Sheng Li
Basic Medical Sciences
Chongqing Medical University
Chongqing
Language: Chinese, English
Contact
Tumor Metabolism Epigenetics Regulation Cancer Biochemistry Molecular Biology Research Oncology Genetics
Areas of Focus
  • Tumor Metabolism and Epigenetic Regulation
Work Experience
  • 2008-2014 - Third Military Medical University, School of Pharmacy - Assistant Laboratory Technician
  • 2014-2015 - Third Military Medical University, Second Affiliated Hospital - Assistant Laboratory Technician
  • 2015-2020 - Third Military Medical University, Second Affiliated Hospital - Assistant Researcher
  • 2020-2022 - Army Medical University, Second Affiliated Hospital - Associate Researcher
  • 2022-present - Chongqing Medical University, School of Basic Medicine - Associate Researcher
Academic Background & Achievements
  • 2004-2008 Bachelor: Third Military Medical University, Medical Laboratory Technology
  • 2010-2013 Master: Third Military Medical University, Microbiology and Biochemical Pharmacy
  • 2019-2022 Doctorate: Army Medical University, Biochemistry and Molecular Biology
  • Hosted 2 National Natural Science Foundation General Projects
  • Hosted 1 National Natural Science Foundation Youth Project
  • Hosted 3 Chongqing Natural Science Foundation General Projects
  • Published 7 SCI papers as first or corresponding author
  • Obtained 2 invention patents
Publications
  • LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1., Li B#, Kang H#, Xiao Y#, Du Y, Xiao Y, Song G, Zhang Y, Guo Y, Yang F, He F*, Yang S*., 2022
  • MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival., Li BS#, Zuo QF#, Zhao YL, Xiao B, Zhuang Y, Mao XH, Wu C, Yang SM, Zeng H, Zou QM*, Guo G*., 2015
  • Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy., Xiao YF#, Li BS#, Liu JJ#, Wang SM, Liu J, Yang H, Hu YY, Gong CL, Li JL*, Yang SM*., 2022
  • miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway., Ma DH#, Li BS#, Liu JJ, Xiao YF, Yong X, Wang SM, Wu YY, Zhu HB, Wang DX*, Yang SM*., 2017
  • Long Noncoding RNA Lnc-TLN2-4:1 Suppresses Gastric Cancer Metastasis and Is Associated with Patient Survival., Wu Y#, Hao N#, Wang S, Yang X, Xiao Y, Yang H, Yang S, Li B*., 2020
  • Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection., Bo-sheng Li#, Yong-liang Zhao#, Gang Guo, Wei Li, En-dong Zhu, Xiao Luo, Xu-hu Mao, Quan-ming Zou, Pei-wu Yu, Qian-fei Zuo, Na Li, Bin Tang, Kai-yun Liu*, Bin Xiao*., 2012
  • Long Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential Biomarker., Zeng S, Xiao YF, Tang B, Hu CJ, Xie R, Yang SM, Li BS*., 2015
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.